Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_assertion type Assertion NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_head.
- NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_assertion description "[Clinical impact of continued crizotinib administration after isolated central nervous system progression in patients with lung cancer positive for ALK rearrangement.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_provenance.
- NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_assertion evidence source_evidence_literature NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_provenance.
- NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_assertion SIO_000772 23584297 NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_provenance.
- NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_assertion wasDerivedFrom befree-2016 NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_provenance.
- NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_assertion wasGeneratedBy ECO_0000203 NP1069095.RA8tcisdLlyKizc-R1xvw8E-ZM1NU2I1wVz4Era_4Qrvc130_provenance.